156 related articles for article (PubMed ID: 36852814)
1. Serum Irisin is Associated with Bone Mineral Density in Postmenopausal T2dm Patients Complicated with Osteoporosis and in Mice with Diabetic Osteoporosis.
Hou X; Xing B; Zhang G; Wu H; Feng N; Li Y; Han G
Curr Protein Pept Sci; 2023; 24(4):355-363. PubMed ID: 36852814
[TBL] [Abstract][Full Text] [Related]
2. Correlation of Serum Estradiol with Bone Mineral Density and Bone Metabolism in Patients of Postmenopausal Type 2 Diabetes Mellitus Complicated with Osteoporosis.
Yang F; Xu Q
Horm Metab Res; 2022 Jul; 54(7):442-449. PubMed ID: 35835144
[TBL] [Abstract][Full Text] [Related]
3. The Association of Pelvic Bone Mineral Density and With Proximal Femoral and Spine Bone Mineral Density in Post-menopausal Women.
Mohseni M; Eisen S; Stum S; Civitelli R
J Clin Densitom; 2022; 25(3):328-333. PubMed ID: 35177349
[TBL] [Abstract][Full Text] [Related]
4. Exercise-Linked Skeletal Irisin Ameliorates Diabetes-Associated Osteoporosis by Inhibiting the Oxidative Damage-Dependent miR-150-FNDC5/Pyroptosis Axis.
Behera J; Ison J; Voor MJ; Tyagi N
Diabetes; 2022 Dec; 71(12):2777-2792. PubMed ID: 35802043
[TBL] [Abstract][Full Text] [Related]
5. The Association of Serum Irisin with Bone Mineral Density and Turnover Markers in New-Onset Type 2 Diabetic Patients.
Wang X; Hu T; Ruan Y; Yao J; Shen H; Xu Y; Zheng B; Zhang Z; Wang J; Tan Q
Int J Endocrinol; 2022; 2022():7808393. PubMed ID: 35265126
[TBL] [Abstract][Full Text] [Related]
6. Circulating irisin is associated with osteoporotic fractures in postmenopausal women with low bone mass but is not affected by either teriparatide or denosumab treatment for 3 months.
Anastasilakis AD; Polyzos SA; Makras P; Gkiomisi A; Bisbinas I; Katsarou A; Filippaios A; Mantzoros CS
Osteoporos Int; 2014 May; 25(5):1633-42. PubMed ID: 24599275
[TBL] [Abstract][Full Text] [Related]
7. Based on HbA1c Analysis: Bone Mineral Density and Osteoporosis Risk in Postmenopausal Female with T2DM.
Gao L; Liu Y; Li M; Wang Y; Zhang W
J Clin Densitom; 2024; 27(1):101442. PubMed ID: 38039558
[TBL] [Abstract][Full Text] [Related]
8. Plasma periostin as a biomarker of osteoporosis in postmenopausal women with type 2 diabetes.
Li J; Niu X; Si Q; Song Q; Jin M; Zhou R; Sun Y; Li J; Wang Q
J Bone Miner Metab; 2021 Jul; 39(4):631-638. PubMed ID: 33566208
[TBL] [Abstract][Full Text] [Related]
9. Calcification of lower extremity arteries is related to the presence of osteoporosis in postmenopausal women with type 2 diabetes mellitus: a cross-sectional observational study.
Xu X; Zhang M; Fei Z; Sheng H; Qu S; Cui R
Osteoporos Int; 2021 Jun; 32(6):1185-1193. PubMed ID: 33411011
[TBL] [Abstract][Full Text] [Related]
10. Irisin is associated with osteoporotic fractures independently of bone mineral density, body composition or daily physical activity.
Palermo A; Strollo R; Maddaloni E; Tuccinardi D; D'Onofrio L; Briganti SI; Defeudis G; De Pascalis M; Lazzaro MC; Colleluori G; Manfrini S; Pozzilli P; Napoli N
Clin Endocrinol (Oxf); 2015 Apr; 82(4):615-9. PubMed ID: 25400208
[TBL] [Abstract][Full Text] [Related]
11. Variations in Irisin, Bone Mineral Density, Bone Mineral Content, and Body Composition After Laparoscopic Bariatric Procedures in Obese Adults.
Lu C; Li Z; Yang J; Feng L; Wang C; Shi Q
J Clin Densitom; 2020; 23(2):244-253. PubMed ID: 31133501
[TBL] [Abstract][Full Text] [Related]
12. Type 2 Diabetes Mellitus Increases the Risk to Hip Fracture in Postmenopausal Osteoporosis by Deteriorating the Trabecular Bone Microarchitecture and Bone Mass.
Mohsin S; Kaimala S; Sunny JJ; Adeghate E; Brown EM
J Diabetes Res; 2019; 2019():3876957. PubMed ID: 31815147
[TBL] [Abstract][Full Text] [Related]
13. Incident Fracture Risk in Type 2 Diabetic Postmenopausal Women in Mainland China: Peking Vertebral Fracture Study.
Jiajue R; Qi X; Jiang Y; Wang Q; Wang W; Pei Y; Wang X; Huang W; Zheng X; Ning Z; Wang O; Li M; Xing X; Yu W; Xu L; Xia W
Calcif Tissue Int; 2019 Nov; 105(5):466-475. PubMed ID: 31511960
[TBL] [Abstract][Full Text] [Related]
14. Prevalence and Risk Factors of Osteoporosis in Postmenopausal Women with Type 2 Diabetes Mellitus.
Raška I; Rašková M; Zikán V; Škrha J
Cent Eur J Public Health; 2017 Mar; 25(1):3-10. PubMed ID: 28399348
[TBL] [Abstract][Full Text] [Related]
15. Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes.
Zhou Y; Li Y; Zhang D; Wang J; Yang H
Diabetes Res Clin Pract; 2010 Dec; 90(3):261-9. PubMed ID: 20950884
[TBL] [Abstract][Full Text] [Related]
16. Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes.
Anaforoglu I; Nar-Demirer A; Bascil-Tutuncu N; Ertorer ME
J Diabetes Complications; 2009; 23(1):12-7. PubMed ID: 18413190
[TBL] [Abstract][Full Text] [Related]
17. Relationship between body composition and bone mineral density in postmenopausal women with type 2 diabetes mellitus.
Gao L; Zhang P; Wang Y; Zhang W; Zhao J; Liu Y; Liu J; He S
BMC Musculoskelet Disord; 2022 Oct; 23(1):893. PubMed ID: 36192772
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of low bone mass in postmenopausal Kuwaiti women residents in the largest province of Kuwait.
Al-Shoumer KA; Nair V
Arch Osteoporos; 2012; 7():147-53. PubMed ID: 23225292
[TBL] [Abstract][Full Text] [Related]
19. Irisin Correlates Positively With BMD in a Cohort of Older Adult Patients and Downregulates the Senescent Marker p21 in Osteoblasts.
Colaianni G; Errede M; Sanesi L; Notarnicola A; Celi M; Zerlotin R; Storlino G; Pignataro P; Oranger A; Pesce V; Tarantino U; Moretti B; Grano M
J Bone Miner Res; 2021 Feb; 36(2):305-314. PubMed ID: 33053231
[TBL] [Abstract][Full Text] [Related]
20. Bone mass loss is associated with systolic blood pressure in postmenopausal women with type 2 diabetes in Tibet: a retrospective cross-sectional study.
Zhou L; Song J; Yang S; Meng S; Lv X; Yue J; Mina A; Puchi B; Geng Y; Yang L
Osteoporos Int; 2017 May; 28(5):1693-1698. PubMed ID: 28154942
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
